#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ewing's sarcoma metastatic Gastrointestinal neuroendocrine tumour Malignant oligodendroglioma Sarcoma Renal cancer metastatic Chronic myeloid leukaemia (in remission) Noonan syndrome Acute promyelocytic leukaemia Neuroendocrine tumour Non-renal cell carcinoma of kidney Ocular myasthenia Gaucher's disease type I Immune-mediated renal disorder Osteogenesis imperfecta Sarcoidosis More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Life with Disease Medulloblastoma Glycogen storage disease type V – Diagnostics Arterial tortuosity syndrome – Trials in Disease SAPHO syndrome – Basic Information Factor VIII deficiency – Trials in Disease Small intestine leiomyosarcoma Acute respiratory distress syndrome – Treatment Short-bowel syndrome Piriformis syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Andexanet Alfa Diclofenac Epolamine Prasugrel Perampanel Arachis Hypogaea Extract Fasudil Hydrochloride Prednisolone Sodium Phosphate Timrepigene Emparvovec MB-CART2219.1 Morphine Sulfate Clomipramine Hydrochloride Ptc518 Selexipag Specific Nucleic Acid Sna-Ebv Intestifix Iloprost Trometamol Dactylis Glomerata Rasagiline Seladelpar Benfotiamine More therapies…

    Learn about Your Condition

    Primary hyperthyroidism Myocardial ischaemia Angelman's syndrome Autoimmune uveitis Haemorrhage intracranial Crohn's disease Cerebellar ataxia Colon cancer stage IV Trigeminal neuralgia Aplastic anaemia Uterine leiomyosarcoma Hepatic cirrhosis Pterygium Colorectal cancer stage II Cerebral palsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the efficacy and safety of obinutuzumab compared to prednisolone in adults with newly onset minimal change disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Nephropathy
    Investigated Drugs:
    • Obinutuzumab
    • Tacrolimus
    • Betamethasone Sodium Phosphate
    Austria France Germany

  • A study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Ipilimumab
    France Germany Italy Poland Spain

  • An exploratory study to evaluate the effect of rimonabant on hand function in patients with cervical spinal cord injury

    Recruiting

    1 1 1
    Investigated Diseases:
    • Spinal cord injury cervical
    Spain

  • A study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis

    Recruiting

    2 1
    Investigated Drugs:
    • AZD1163
    Bulgaria Germany Hungary Poland Spain

  • A study to evaluate the effectiveness and safety of efaglomograstim alfa in patients with low blood platelet counts caused by chemotherapy

    Recruiting

    3 1
    Bulgaria France Poland Romania Spain

  • A study to evaluate the effectiveness of NNC0662-0419 and semaglutide in people with type 2 diabetes

    Recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Croatia Hungary Poland Portugal Slovakia Spain
Previous Page
1 … 25 26 27 28 29 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!